US FDA approves Merck's combination HIV treatment-April 2024-www.financetom.com

US FDA approves Merck's combination HIV treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Merck's combination HIV treatment

Apr 21, 2026 9:09 AM

April 21 (Reuters) - The U.S. Food and Drug

Administration approved Merck's ( MRK ) once-daily, oral,

combination regimen for HIV infections, the health regulator's

website showed on Tuesday.

Previous page： Russia-Ukraine crisis: Meet the 3 oligarchs sanctioned by UK Next page： The Oligarchs: Here are Russia’s five richest individuals

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Russia-Ukraine crisis: Meet the 3 oligarchs sanctioned by UK

Feb 23, 2022

While Boris Johnson's sanctions have been called 'peashooters' in face of the Russian action in Ukraine, Russia’s super-rich have lost $32 billion in combined wealth this year.

The Oligarchs: Here are Russia’s five richest individuals

Feb 23, 2022

Russia is famous for its oligarchs, who emerged in the wake of the dissolution of the USSR, when rampant corruption saw accumulation of fabulous wealth in the hands of a few.

Russia-Ukraine conflict: Moody's says global oil, natural gas prices may see sharp rise

Feb 23, 2022

Tensions have been escalating between Ukraine and Russia in recent weeks, and on Monday Moscow decided to recognize two separatist regions of eastern Ukraine as independent and deployed Russian troops there.

Supply chain bottlenecks to worsen as Russia-Ukraine conflict spirals

Feb 23, 2022

Besides sending energy prices sky-high, the Russia-Ukraine crisis will have a disastrous impact on the supply chain of foodgrains and metals across the world, with Europe the worst sufferer. And Germany will hurting particularly hard.